✦ LIBER ✦

Results in hairy-cell leukemia patients treated with α-interferon: Predictive prognostic factors

✍ Scribed by P. L. Zinzani; F. Lauria; D. Raspadori; D. Rondelli; D. Benfenati; S. Pileri; E. Sabattini; S. Tura

Book ID: 114791598
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 440 KB
Volume: 49
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1992.tb00917.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unilateral seizures in a patient with ha

Unilateral seizures in a patient with hairy cell leukemia treated with interferon

✍ Dierckx, R.A.; Michotte, A.; Schmedding, E.; Ebinger, G.; Degeeter, T.; van Camp 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Bone marrow changes in patients with hai

Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha2-interferon

✍ Faramarz Naeim; Andrew D. Jacobs 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 793 KB

Prognostic factors and survival in patie

Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-α

✍ Fosså, S.D.; Kramar, A.; Droz, J.-P. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 603 KB

Prognostic factors for survival in patie

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-α

✍ Luciano Canobbio; Alessandra Rubagotti; Loredana Miglietta; Daniela Cannata; Ant 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 356 KB

Recombinant beta-serine-interferon in ha

Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon

✍ John A. Glaspy; Steven G. Marcus; Jan Ambersley; David W. Golde 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 1 views

Ten patients with hairy cell leukemia (HCL) requiring therapy were treated with recombinant beta-serineinterferon (rIFN-Bser) (90 X lo6 units [Ul subcutaneously three times a week). Eight patients were evaluable for response and nine for toxicity. Five patients (63%) showed normalization of peripher

Toxicity and bone marrow response of pat

Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosynthetic (recombinant) ?-2-interferon

✍ Jacobs, A. D. ;Naiem, F. ;Champlin, R. E. ;Golde, D. W. 📂 Article 📅 1985 🏛 Springer-Verlag ⚖ 87 KB